Epigenetics Lab December 1, 2008 Goals of today’s lab: 1.Understand the basic molecular techniques used in the lab to study epigenetic silencing in cancer.

Slides:



Advertisements
Similar presentations
Methylation of individual CpG sites within p16 CpG islands in various human gastric lesions Zheming Lu( 陆哲明) Dajun Deng (邓大君) Beijing University School.
Advertisements

Estrogen and its receptors play an important role in breast carcinogenesis. In humans, there are two subtypes of estrogen receptors (ER), ER  and ER ,
Genomic walking (1) To start, you need: -the DNA sequence of a small region of the chromosome -An adaptor: a small piece of DNA, nucleotides long.
The virochip (UCSF) is a spotted microarray. Hybridization of a clinical RNA (cDNA) sample can identify specific viral expression.
Remember the limitations? –You must know the sequence of the primer sites to use PCR –How do you go about sequencing regions of a genome about which you.
19.1 Techniques of Molecular Genetics Have Revolutionized Biology
Using a Single Nucleotide Polymorphism to Predict Bitter Tasting Ability Lab Overview.
Chapter 10: Genetic Engineering- A Revolution in Molecular Biology.
Chapter 20: DNA Technology and Genomics - Lots of different techniques - Many used in combination with each other - Uses information from every chapter.
Trends Biomedical Science
Supplementary Table S1. Patient demographics of the RRBS discovery set. Characteristics RRBS discovery set TotalIDH1/2 WT IDH1 MUT No. of Patients
March 6, 2016 EpiQ Chromatin Analysis Kit A New Tool for Epigenetic Research Gábor Kohut PhD Field Application Specialist Central and Eastern Europe.
Date of download: 9/19/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Germline Epigenetic Regulation of KILLIN in Cowden.
Dataset S1 – KvDMR bisulphite cloning analysis Bisulphite PCR products containing 23 CpG dinucleotides were cloned and sequenced from human EB trophoblast.
Volume 46, Issue 6, Pages (December 2004)
Xiang Qian, Long Jin, Elzbieta Kulig, Ricardo V. Lloyd 
Figure 1. miRNA processing and primer design
Distribution of CpG dinucleotide in the human genome and differences in methylation patterns between normal and tumor cells. In the majority of the mammalian.
PCR Polymerase Chain Reaction
Primer design.
Figure 1. MORT gene silencing is early event in cancer
Silencing NKD2 by Promoter Region Hypermethylation Promotes Esophageal Cancer Progression by Activating Wnt Signaling  Baoping Cao, MD, PhD, Weili Yang,
Chapter 20: DNA Technology and Genomics
Volume 63, Issue 6, Pages (June 2013)
Promoter Methylation and Differential Expression of π-Class Glutathione S-Transferase in Endometrial Carcinoma  Queeny K.Y. Chan, Ui-Soon Khoo, Kelvin.
by Hong Yin, and K. L. Blanchard
Hypomethylation Status of CpG Sites at the Promoter Region and Overexpression of the Human MDR1 Gene in Acute Myeloid Leukemias by Masaharu Nakayama, Morimasa.
Volume 133, Issue 6, Pages (December 2007)
Volume 136, Issue 2, Pages e1 (February 2009)
MethySYBR, a Novel Quantitative PCR Assay for the Dual Analysis of DNA Methylation and CpG Methylation Density  Pang-Kuo Lo, Hanano Watanabe, Pi-Chun.
Volume 116, Issue 2, Pages (February 1999)
Epigenetic Inhibition of Nuclear Receptor Small Heterodimer Partner Is Associated With and Regulates Hepatocellular Carcinoma Growth  Nan He, Kyungtae.
Detection of Aberrant TERT Promoter Methylation by Combined Bisulfite Restriction Enzyme Analysis for Cancer Diagnosis  Seungjae Lee, Sumit Borah, Armita.
Discordance between Genetic and Epigenetic Defects in Pseudohypoparathyroidism Type 1b Revealed by Inconsistent Loss of Maternal Imprinting at GNAS1 
Genetics supersedes epigenetics in colon cancer phenotype
GATA2 is Epigenetically Repressed in Human and Mouse Lung Tumors and Is Not Requisite for Survival of KRAS Mutant Lung Cancer  Mathewos Tessema, PhD,
Volume 133, Issue 6, Pages (December 2007)
Differential DNA Methylation as a Tool for Noninvasive Prenatal Diagnosis (NIPD) of X Chromosome Aneuploidies  Floriana Della Ragione, Paola Mastrovito,
Volume 4, Issue 5, Pages (November 2003)
S. Sesselmann, M. D. , S. Söder, M. D. , R. Voigt, J. Haag, Ph. D. , S
Volume 124, Issue 3, Pages (March 2003)
Volume 42, Issue 4, Pages (April 2005)
Supplementary Figure 3. Bisulfite sequencing of FLJ21062 and ONECUT2 CpG islands. The relative positions of the forward (left-most) and reverse (right-most)
S. Hussain Askree, Shika Dharamrup, Lawrence N. Hjelm, Bradford Coffee 
Custom-Designed MLPA Using Multiple Short Synthetic Probes
Volume 54, Issue 5, Pages (November 1998)
Syed Hussain Askree, Lawrence N
Hypermethylation of estrogen receptor-α gene in atheromatosis patients and its correlation with homocysteine  Yu-Shan Huang, Yan-Fang Zhi, Shu-Ren Wang 
Imprinting at the SMPD1 Locus: Implications for Acid Sphingomyelinase–Deficient Niemann-Pick Disease  Calogera M. Simonaro, Jae-Ho Park, Efrat Eliyahu,
Epigenetics modification
Genetics supersedes epigenetics in colon cancer phenotype
Epigenetic Silencing of SPINT2 Promotes Cancer Cell Motility via HGF-MET Pathway Activation in Melanoma  Soonyean Hwang, Hye-Eun Kim, Michelle Min, Rekha.
Germline Epigenetic Silencing of the Tumor Suppressor Gene PTPRJ in Early-Onset Familial Colorectal Cancer  Ramprasath Venkatachalam  Gastroenterology 
Volume 13, Issue 24, Pages (December 2003)
Novel Polymorphism in the FMR1 Gene Resulting in a “Pseudodeletion” of FMR1 in a Commonly Used Fragile X Assay  Thomas M. Daly, Arash Rafii, Rick A. Martin,
The human GPR109A promoter is methylated and GPR109A expression is silenced in human colon carcinoma cells. The human GPR109A promoter is methylated and.
Volume 124, Issue 5, Pages (May 2003)
Xing-Wei Liang, Ph. D. , Zhao-Jia Ge, M. S. , Lei Guo, Ph. D
Imprinting of Human GRB10 and Its Mutations in Two Patients with Russell-Silver Syndrome  Hiroshi Yoshihashi, Katsuhiro Maeyama, Rika Kosaki, Tsutomu.
Chapter 20: DNA Technology and Genomics
Volume 131, Issue 6, Pages (December 2006)
Practical Contents DNA Extraction Gel Electrophoresis
Molecular Therapy - Nucleic Acids
Methylation status of IGFBPL1 in human breast cancer.
Epigenetic regulation of p16INK4a in human gastric cancer.
The ACIN1 Gene is Hypermethylated in Early Stage Lung Adenocarcinoma
DNA demethylation reactivates GSN expression in gastric cancer cells.
Methylation-specific PCR of APC, RASSF1A, and p14ARF genes in bladder tumor and urine DNAs. In the APC gel panel viewed from left to right, the first (TCC34)
CpG Methylation Analysis—Current Status of Clinical Assays and Potential Applications in Molecular Diagnostics  Antonia R. Sepulveda, Dan Jones, Shuji.
K. Miura, M. Obama, K. Yun, H. Masuzaki, Y. Ikeda, S. Yoshimura, T
Presentation transcript:

Epigenetics Lab December 1, 2008 Goals of today’s lab: 1.Understand the basic molecular techniques used in the lab to study epigenetic silencing in cancer 2.Analyze primary data and draw conclusions 3.Design DNA primers for future experiments

Restriction Sensitive Southern Draw the bands that you would expect of the following digests. Lane 1: Normal tissue undigested Lane 2: Normal tissue digested with RE1 Lane 3: Normal tissue digested with MSRE1 Lane 4: Tumor tissue undigested Lane 5: Tumor tissue digested with RE1 Lane 6: Tumor tissue digested with MSRE CpG Island bp RE1 and MSRE1 cut site

Follow up questions to restriction enzyme southern 1.What would you expect the digest of a tumor sample that is 50% methylated to look like? 2.Why is the non-methylation sensitive restriction digest a necessary control? 3.Why is a parent band digest needed?

Sodium Bisulfite Conversion Write the following sequence after bisulfite conversion: 5’ CATCCGTTACCGTTGGGCTCGAAA 3’ 1.If unmethylated 2.If methylated Follow-up question: 1. If you wanted to perform PCR in a methylated sensitive manner - would you do PCR before or after sodium bisulfite conversion? Why?

Primer Design Take the following sequence and design a forward (or sense) and reverse (or anti sense) primer to amplify this sequence. Start with the base pair that is underlined and work in the 5’ to 3’ direction. Primers must be between base pairs. Underlining is fine. Make sure you annealing temperatures match. 5’ ACAGATCTGGGTACAACTGACACGGACTTGAC 3’ 3’ TGTCTAGACCCATGTTGACTGTGCCTGAACTG 5’ Remember 4 C/G + 2 A/T

Example of MSP Data Why does the second sample have bands in both the Methylated and Unmethylated lanes? 1 2

Assignment Part I: Analyzing MSP Data After looking at the MSP data answer the following questions: 1.Is this gene methylated in normal tissue (if so, how often)? 2.Is this gene methylated in tumor samples (if so, how often)? 3.Based on the MSP data from Normal/Tumor pairs - would you hypothesize Gene X is a TSG or an oncogene? Why? 4.Why is normal tissue DNA methylation a good control?

MSP for Gene X Here is the data from a recent survey of 12 breast cancer patients - looking for DNA methylation of Gene X –N = Normal T= Tumor –U = Unmethylated M= Methylated

Create MSP primers You have the DNA sequence to the CpG island of a known TSG –To determine the methylation status of this gene in tumor samples you are planning on using MSP (since you are now an expert) You must design MSP primers (both Sense and Anti-sense and Methylated and Unmethylated)

For Homework: Criteria for MSP primers Each primer: –Must encompass 3 CpGs –Each primer must be between bp –Methylated S and AS primers must have the same melting temperatures (4 G/C + 2 A/T) –Unmethylated pair must match as well –Account for each unmethylated Cytosines to be converted into a Uracil (both CpG and C) –Remember you only have the Sense strand of DNA (you must account for the anti-sense) –Your PCR product should be between bp –All primers (S and AS) are written 5’ to 3’ –Please write down sequence to primers as well as underlining on the sequence

CpG island to design MSP primers from: Written 5’ to 3’ (remember this is only written single stranded) 1 CGGGTCCCACCTCGCAGGCCAGCTGGAGGGCGCGATCCTGGCGTCCCCCG 53 ACGGCCTGGGGCCCCAATCCAGAGGCCTGGGTGGGAGGGGACCAAGGGT 102 GTAGTAAGGAAGCGCCTTTTGCTGGAGGGCAACGGACCGGGGCGGGGAGTC 153 GGGAGACCAGAGTGGGAGGAAGGCGGGGAGTCCAGGTTCCGCCCCGGAGCC 204 GACTTCCTCCTGGTCGGCGGCTGCAGCGGGGTGAGCGGCGGCAGCGGCCGGG 256 GATCCTGGAGCCATGGGGCGCGCGCGCGACGCCATCCTGGATGCGCTGGA 306 GAACCTGACCGCCGAGGAGCTCAAGAAGTTCAAGCTGAAGCTGCTGTCGGTG 358 CCGCTGCGCGAGGGCTACGGGCGCATCCCGCGGGGCGCGCTGCTGTCCATGGA 411 CGCCTTGGACCTCACCGACAAGCTGGTCAGCTTCTACCTGGAGACCTACGGC

After analyzing the MSP and reverse transcriptase PCR from breast cancer cells lines analyze the following questions 1.Do methylation and gene expression correlate? If so, in what way? 2.Why can’t we just do PCR directly from RNA? 3.Why is ß-actin shown for each sample? 4.Does this data support or refute your conclusions from part I? Comparing Methylation and Expression Data

MSP for gene X Reverse Transcriptase PCR for gene X

Analyzing bisulfite sequencing results Draw the lollipop figure of DNA methylation status for the following 2 sequences: Original sequence: 5’ ACGTCGCGTCCACCGCGTAAGGTCGCTCGACGATCGTCG 3’ Sequence of clone #1: 5’ATGTTGTGTTTATCGCGTAAGGTTGTTTGACGATCGTCG 3’ Sequence of clone #2: 5’ ACGTCGCGTTTATCGCGTAAGGTCGTTCGACGATCGTCG 3’

Follow up questions to bisulfite sequencing analysis 1.Which clone #1 or #2 would you hypothesize came from the tumor and which from the normal tissue? Why? 2.If you had an unknown tissue sample and you wanted to know the methylation status of your favorite gene. What technique would you use and why? 3.Which technique to you think would be most suited to look at the effects of epigenetic therapy (DNA methylation inhibitors) on a tumor sample? Why?